Revenue Summary of Adimmune Corporation

Adimmune Corporation's latest annual revenue in 2023 was 1.78 Billion TWD , down -20.72% from previous year.
Adimmune Corporation's latest quarterly revenue in 2024 Q2 was 79.8 Million TWD , up 81.87% from previous quarter.
Adimmune Corporation reported a annual revenue of 2.25 Billion TWD in annual revenue 2022, up 37.21% from previous year.
Adimmune Corporation reported a annual revenue of 1.64 Billion TWD in annual revenue 2021, down -12.2% from previous year.
Adimmune Corporation reported a quarterly revenue of 79.8 Million TWD for 2024 Q2, up 81.87% from previous quarter.
Adimmune Corporation reported a quarterly revenue of 559.49 Million TWD for 2023 Q4, down -42.52% from previous quarter.

Annual Revenue Chart of Adimmune Corporation (2023 - 2009)

Historical Annual Revenue of Adimmune Corporation (2023 - 2009)

Year	Revenue	Revenue Growth
2023	1.78 Billion TWD	-20.72%
2022	2.25 Billion TWD	37.21%
2021	1.64 Billion TWD	-12.2%
2020	1.86 Billion TWD	43.81%
2019	1.29 Billion TWD	58.04%
2018	822.36 Million TWD	46.14%
2017	562.74 Million TWD	-7.25%
2016	606.72 Million TWD	108.69%
2015	290.73 Million TWD	-39.49%
2014	480.5 Million TWD	16.04%
2013	414.09 Million TWD	6.96%
2012	387.16 Million TWD	33.34%
2011	290.36 Million TWD	-65.22%
2010	834.77 Million TWD	-39.06%
2009	1.36 Billion TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	43.87 Million TWD	-92.16%
2024 Q2	79.8 Million TWD	81.87%
2023 Q4	559.49 Million TWD	-42.52%
2023 FY	1.78 Billion TWD	-20.72%
2023 Q3	973.34 Million TWD	1079.11%
2023 Q1	169.71 Million TWD	-70.97%
2023 Q2	82.54 Million TWD	-51.36%
2022 FY	2.25 Billion TWD	37.21%
2022 Q1	52.79 Million TWD	-93.34%
2022 Q2	526.93 Million TWD	898.02%
2022 Q4	584.6 Million TWD	-46.23%
2022 Q3	1.08 Billion TWD	106.34%
2021 FY	1.64 Billion TWD	-12.2%
2021 Q4	792.77 Million TWD	5.24%
2021 Q1	6.93 Million TWD	-99.16%
2021 Q2	88.01 Million TWD	1170.07%
2021 Q3	753.33 Million TWD	755.91%
2020 Q3	617.72 Million TWD	879.31%
2020 Q2	63.07 Million TWD	-82.81%
2020 Q1	367.01 Million TWD	-41.5%
2020 Q4	821.33 Million TWD	32.96%
2020 FY	1.86 Billion TWD	43.81%
2019 Q3	506.8 Million TWD	381.26%
2019 FY	1.29 Billion TWD	58.04%
2019 Q1	60.18 Million TWD	-85.2%
2019 Q2	105.3 Million TWD	74.97%
2019 Q4	627.39 Million TWD	23.79%
2018 Q3	315.06 Million TWD	934.45%
2018 FY	822.36 Million TWD	46.14%
2018 Q4	406.6 Million TWD	29.06%
2018 Q2	30.45 Million TWD	-56.64%
2018 Q1	70.24 Million TWD	-66.76%
2017 Q2	50 Million TWD	-33.67%
2017 FY	562.74 Million TWD	-7.25%
2017 Q3	226.03 Million TWD	352.06%
2017 Q1	75.38 Million TWD	-74.56%
2017 Q4	211.31 Million TWD	-6.51%
2016 Q3	153.89 Million TWD	38.13%
2016 FY	606.72 Million TWD	108.69%
2016 Q1	45.07 Million TWD	-64.41%
2016 Q2	111.4 Million TWD	147.19%
2016 Q4	296.35 Million TWD	92.57%
2015 Q4	126.64 Million TWD	16.41%
2015 FY	290.73 Million TWD	-39.49%
2015 Q3	108.78 Million TWD	295.2%
2015 Q1	27.78 Million TWD	-81.23%
2015 Q2	27.52 Million TWD	-0.91%
2014 Q3	66.67 Million TWD	-74.42%
2014 Q4	148.03 Million TWD	122.01%
2014 Q1	5.18 Million TWD	-96.31%
2014 FY	480.5 Million TWD	16.04%
2014 Q2	260.61 Million TWD	4930.23%
2013 Q3	125.47 Million TWD	-11.44%
2013 Q1	6.63 Million TWD	-95.74%
2013 FY	414.09 Million TWD	6.96%
2013 Q4	140.29 Million TWD	11.81%
2013 Q2	141.68 Million TWD	2035.1%
2012 Q2	115.15 Million TWD	263.38%
2012 Q4	155.59 Million TWD	83.64%
2012 Q3	84.72 Million TWD	-26.42%
2012 Q1	31.68 Million TWD	-59.65%
2012 FY	387.16 Million TWD	33.34%
2011 Q3	79.16 Million TWD	-10.61%
2011 FY	290.36 Million TWD	-65.22%
2011 Q4	78.53 Million TWD	-0.79%
2011 Q2	88.55 Million TWD	100.71%
2011 Q1	44.11 Million TWD	-24.01%
2010 Q3	47.56 Million TWD	0.0%
2010 FY	834.77 Million TWD	-39.06%
2010 Q4	58.05 Million TWD	22.05%
2009 FY	1.36 Billion TWD	0.0%

Peer Revenue Comparison of Adimmune Corporation

Name	Revenue	Revenue Difference
Apex Biotechnology Corp.	1.67 Billion TWD	-6.475%
Sinphar Pharmaceutical Co.,Ltd.	2.96 Billion TWD	39.752%
Panion & Bf Biotech Inc.	1.88 Billion TWD	5.143%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	2.08 Billion TWD	14.443%
GenMont Biotech Incorporation	318.01 Million TWD	-461.324%
Abnova (Taiwan) Corporation	382.05 Million TWD	-367.238%
Tanvex BioPharma, Inc.	61.41 Million TWD	-2806.798%
Polaris Group	7.48 Million TWD	-23761.703%
Energenesis Biomedical CO.,LTD.	7.15 Million TWD	-24838.446%
UnicoCell Biomed Co., Ltd.	24.58 Million TWD	-7159.726%
PELL Bio-Med Technology Co. Ltd.	18.03 Million TWD	-9799.041%

Global Stocks Search

Adimmune Corporation (4142.TW)

Revenue Summary of Adimmune Corporation

Annual Revenue Chart of Adimmune Corporation (2023 - 2009)

Historical Annual Revenue of Adimmune Corporation (2023 - 2009)

Peer Revenue Comparison of Adimmune Corporation